PPARGC1A and metabolic dysfunction-associated steatohepatitis: PGC1α have been implicated in NASH-HCC pathogenesis, due to can regulate several metabolic pathways, such as gluconeogenesis, mitochondrial biogenesis, as well as FA oxidation, the antioxidant response, and de novo lipogenesis (DNL) [195].